|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT00615953 |
|
Date of registration:
|
03/02/2008 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
American Norditropin Studies - Registry of Growth Hormone (GH) Patients
ANSWERProg |
|
Scientific title:
|
American Norditropin Studies: Web-Enabled Research (The ANSWER Program) ID#: HGH-2149 |
|
Date of first enrolment:
|
May 2007 |
|
Target sample size:
|
79 |
|
Recruitment status: |
Suspended |
|
URL:
|
http://clinicaltrials.gov/show/NCT00615953 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case-Only, Time Perspective: Prospective
|
|
Phase:
|
N/A
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Nancy E. Friedman, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Duke University |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients on Norditropin GH
Exclusion Criteria:
- Patients not on Norditropin GH
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Growth Hormone Deficiency
|
|
Intervention(s)
|
|
Drug: Norditropin Growth Hormone
|
|
Secondary ID(s)
|
|
HGH-2149
|
|
Pro00000557
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|